Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Adicet Bio stock

Learn how to easily invest in Adicet Bio stock.

Adicet Bio Inc is a biotechnology business based in the US. Adicet Bio shares (ACET) are listed on the NASDAQ and all prices are listed in US Dollars. Adicet Bio employs 86 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Adicet Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Adicet Bio stock price (NASDAQ: ACET)

Use our graph to track the performance of ACET stocks over time.

Adicet Bio shares at a glance

Information last updated 2022-06-25.
Latest market close$14.58
52-week range$6.25 - $21.17
50-day moving average $12.84
200-day moving average $12.45
Wall St. target price$28.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.05

Buy Adicet Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adicet Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adicet Bio price performance over time

Historical closes compared with the close of $14.58 from 2022-06-29

1 week (2022-06-24) 6.97%
1 month (2022-05-28) N/A
3 months (2022-03-30) -25.50%
6 months (2021-12-31) -16.64%
1 year (2021-07-01) 50.31%
2 years (2020-07-01) 607.77%
3 years (2019-07-01) 41.69%
5 years (2017-06-27) N/A

Is Adicet Bio stock undervalued or overvalued?

Valuing Adicet Bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adicet Bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Adicet Bio's PEG ratio

Adicet Bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.82. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Adicet Bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Adicet Bio financials

Revenue TTM $38.7 million
Gross profit TTM $9.7 million
Return on assets TTM -7.15%
Return on equity TTM -13.18%
Profit margin -93.18%
Book value $7.80
Market capitalisation $545.3 million

TTM: trailing 12 months

Adicet Bio share dividends

We're not expecting Adicet Bio to pay a dividend over the next 12 months.

Have Adicet Bio's shares ever split?

Adicet Bio's shares were split on a 1:7 basis on 15 September 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adicet Bio shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Adicet Bio shares which in turn could have impacted Adicet Bio's share price.

Adicet Bio overview

Adicet Bio, Inc. , a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

Frequently asked questions

What percentage of Adicet Bio is owned by insiders or institutions?
Currently 11.016% of Adicet Bio shares are held by insiders and 86.229% by institutions.
How many people work for Adicet Bio?
Latest data suggests 86 work at Adicet Bio.
When does the fiscal year end for Adicet Bio?
Adicet Bio's fiscal year ends in June.
Where is Adicet Bio based?
Adicet Bio's address is: 200 Clarendon Street, Boston, MA, United States, 02116
What is Adicet Bio's ISIN number?
Adicet Bio's international securities identification number is: US0070021086
What is Adicet Bio's CUSIP number?
Adicet Bio's Committee on Uniform Securities Identification Procedures number is: 004446100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site